For Tuesday, February 15th
SKGP, DEGH, DNAG, UNDT, LLNW, MRES
Our Stocks to Watch today include IceWEB Inc. (OTCBB: IWEB), Attitude Drinks Inc. (OTCBB: ATTD), Smart Kids Group Inc. (OTCBB: SKGP), Double Eagle Holdings Ltd. (OTCBB: DEGH), DNAPrint Genomics Inc. (OTCBB: DNAG), Universal Detection Technology Corp. (OTCBB: UNDT), Limelight Networks Inc. (Nasdaq: LLNW) and Neuro-Biotech Corp. (OTC: MRES).
ICEWEB INCORPORATED (OTCBB: IWEB)
Detailed Quote: http://www.otcpicks.com/quotes/IWEB.php
Company Profile: http://otcpicks.com/IceWEB-Inc.htm
Incorporated in 1994, IceWEB was highly successful in the federal computing space working with unstructured geospatial data, as well as managing and storing block data as an ASP in the enterprise and federal space. The company was twice named Inc. Magazine’s Inc. 500 Fastest Growing private US corporations and was recognized as Deloitte & Touche Technology Fast 500 North American public or private technology companies. Following on this success, the company developed and expanded on the rich storage management features to bring to market a versatile, all-inclusive storage system aggressively priced for the commercial mid-market space. The IceWEB Storage System is a high-performance unified storage platform for file and block data of all kinds that’s easy to install, and provides built-in, all-inclusive storage management features including de-duplication; unlimited snapshots; thin provisioning; local or remote, real-time or scheduled replication; capacity and utilization reporting, and VMware integration.
February 15 - IceWEB Reports Fiscal First Quarter Financial Results and Projects $2 Million Plus Second Quarter Shipments
Year-Over-Year Revenues Increased 13%; Future Shipment Pipeline Maintained at More Than $10 Million
IceWEB™, Inc. (OTCBB: IWEB), a leading provider of unified data storage and building blocks for cloud storage, announced today results for the fiscal 2011 first quarter period ended December 31, 2010.
Quarterly Highlights and Recent Developments
* Revenue increased 13% over year-ago period
* Gross margins maintained at 48%
* Order flow accelerating as channel partners ramp up efforts
* Second quarter storage shipments projected at over $2 million
* Future shipment pipeline continues to grow and exceeds $10 million
In the quarter ending December 31, 2010, the Company reported revenue of $677,853, as compared to quarterly revenue of $600,817 for the year-ago period. The year-over-year increase in revenue was due to the increase in data storage product sales versus the year-ago quarter. For the three month period ending December 31, 2010, the Company reported a loss of $1,255,815, versus a loss of $1,459,634 for the year-ago period.
Gross margin was 48% for the three months ending December 31, 2010, down slightly from 54% in the year earlier period.
The Company reports results on both a GAAP and a non-GAAP basis. Non-GAAP results excludes the impact of equity-based compensation and amortization of intangible assets, and includes the unrealized gain on marketable securities.
John R. Signorello, Chairman and CEO, stated, "The first quarter of fiscal 2011 attained our internal growth plans while maintaining a tight control on overhead expenses. We have diminished our cash burn level in the quarter and believe we are nearing revenue levels to be cash flow neutral."
"Our experienced sales professionals, combined with the key alliances with established distributors such as Promark Technologies, give us confidence that our ambitious sales and earnings goals will be attained. Evidence of this growing success is seen in our Channel Sales Model that is continuing to mature and is now delivering new orders at an accelerated rate. We are very confident that storage sales revenues in the second quarter will exceed $2 million," concluded, Signorello.
Karl Chen, VP or Worldwide Channel Sales and Marketing, stated, "In addition, we have also seen our pipeline of future business opportunities continue to grow and is now over $10 million; a direct result of our strong distribution network, that will be expanding further in coming months. Noting the accelerating order inflow for our storage platform and the rousing acceptance of our recently announced IceWEB 3000 Storage System, leads us to anticipate that an upward revision of our goals may be appropriate in the near future."
Mr. Signorello noted, "The massive amounts of data that are being generated daily will require a vast number of storage systems to both store and manage the data. EMC, a leader in the storage industry, recently sponsored an IDC report "The Digital Universe Decade" that in the period from 2009-2020, the digital universe is expected to grow by a factor of 44."
Mr. Signorello concluded, "We are very confident that the steps we have taken are positioning IceWEB as a key supplier in this burgeoning market."
ATTITUDE DRINKS INCORPORATED (OTCBB: ATTD)
Detailed Quote: http://www.otcpicks.com/quotes/ATTD.php
Company Profile: http://otcpicks.com/Attitude-Drinks.htm
Attitude Drinks Inc. is an innovative, beverage brand development company with a focus on functional milk, ready-to-drink beverages. Phase III® Recovery Drink is the company's first, functional milk drink exploiting recent scientific evidence of the benefits of milk and protein as an exercise recovery aid. The February 2010 launch of Phase III marks the first time a sports drink has been formulated from real milk.
February 3 - Attitude Drinks Teams With Dora's Naturals to Bring Phase III® to Retailers in New York
Attitude Drinks (OTCBB: ATTD), an innovative beverage brand development company, announced today that it has signed an agreement with Dora's Naturals, a major natural food distributor in the Northeastern United States, to sell its Phase III® Recovery Drink to retailers in the state of New York. Dora's will sell and merchandise Phase III in the boroughs of New York City and the NY suburbs of Long Island and Westchester. This comprises most of the New York Market, the second largest in the U.S. after Los Angeles.
U.S. sales of healthy foods, which includes functional beverages, topped $143 billion in 2009 and is forecast to reach $217 billion by 2017, according to the Nutrition Business Journal. Marty Jay Zirofsky, Director of Beverages at Dora's Naturals, commented, "This is an exciting opportunity to include an innovative and functional beverage line into our extensive beverage portfolio. We are pleased to add Phase III, which is a protein drink and a lot more."
Roy Warren, CEO of Attitude, stated, "Dora's Naturals is the perfect partner to capitalize on the hottest consumer buying trends. Phase III's pure-milk based formulation and eco-friendly bottle fit in perfectly with the premium, good-for-you food and beverages represented by Dora's Naturals."
Jack Shea, Executive VP of Sales at Attitude, said, "This will be a great partnership. Phase III is a cutting-edge and clinically-proven solution for muscle recovery after a workout, whether you are a serious or recreational athlete. The agreement with Dora's Naturals allows us to ramp up sales and distribution in the New York Metro area quickly."
ABOUT DORA'S NATURALS
Founded in 1998, Dora's Naturals is a privately held natural and organic food and beverage distributor based in South Hackensack, New Jersey. The company's mission is to provide the highest quality, perishable, natural, organic and specialty foods and beverages to retailers in the Northeastern United States.
STOCKS TO WATCH
SMART KIDS GROUP INCORPORATED (OTCBB: SKGP)
"Up 262.50% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SKGP.php
Smart Kids Group develops, distributes and licenses quality children's character-based Edutainment products through a variety of media including television, DVD, retail, direct marketing, and the Internet.
February 15 - Smart Kids Group Inc. Announces the Rights to Produce The Adventures of Bert and Clare, a 3D Fully Animated Television Series
Smart Kids Group Inc. (OTCBB: SKGP), a global provider of children's digital education and entertainment, announces the rights to produce The Adventures of Bert and Clare™, a 3D fully animated television series consisting of 65 shows.
CEO Richard Shergold is pleased to announce the rights to produce The Adventures of Bert and Clare, a 3D fully animated television series consisting of 65 shows. The company — with locations in Ft. Lauderdale, Florida and Edmonton, Alberta, Canada — is uniquely situated to take advantage of entertainment opportunities emerging in the children's entertainment field.
Smart Kids Productions will be instrumental in bringing the new series, The Adventures of Bert and Clare™, to the mainstream public. Additionally, the company is repackaging the current series of Be Alert Bert®, Full Motion Fitness™, the songs and story books. Smart Kids Productions also has the full rights to produce Full Motion Fitness 2™.
DOUBLE EAGLE HOLDINGS (OTCBB: DEGH)
"Up 19.35% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/DEGH.php
Double Eagle Holdings, Ltd. does not have significant operations. Previously, the company was engaged in investing and revitalizing single family homes in established residential neighborhoods in suburban areas. The company was founded in 1985. It was formerly known as Network Systems International, Inc. and changed its name to Onspan Networking, Inc. in 2001. Further, the company changed its name to Double Eagle Holdings, Ltd. in 2006. Double Eagle Holdings is based in Charlotte, North Carolina.
January 12 - Double Eagle Releases Income Statement
Double Eagle Holdings, Ltd. (OTCBB: DEGH) has released its most recent income statement. Visit http://yhoo.it/hU3kHG to view it.
DNAPRINT GENOMICS (OTCBB: DNAG)
"Up 50.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/DNAG.php
DNAPrint Genomics, Inc. engages in the research and development of genomic products, and provides scientific services and tests to the genealogy, forensic, pharmaceutical, and genetics markets in the United States. Its primary product under development is PT-401, a "Super EPO" (erythropoietin) dimer protein drug for treatment of anemia in renal dialysis patients. The company's other products under development include PT-501 for the treatment of attention deficit hyperactivity disorder; PT-502 for the treatment of drug addiction; and PT-503 for the treatment of depression. DNAPrint Genomics also develops diagnostic tests, including OVANOME for ovarian cancer, STATINOME for the safety of statins, DIABETES-CD59 for pre-diabetes diabetic complications; and PONV for post-operative nausea and vomiting. In addition, it offers DNAWitness product suite for the forensics market to determine genetic heritage from DNA samples obtained from crime scenes; and ANCESTRYbyDNA and EURO-DNA, which are genealogy products that provide an inference of an individual's genetic ancestry or heritage. Further, the company provides sequencing and genotyping services to industrial customers. DNAPrint Genomics has strategic alliances with Moffitt Cancer Center, and Beth Israel Deaconess Medical Center; and a collaborative research agreement with Beth Israel. It also has a license agreement with Harvard Medical School, and a research sponsorship agreement with Massachusetts College of Pharmacy and Health Sciences. The company, formerly known as Lexington Energy, Inc., was incorporated in 1983 and is based in Sarasota, Florida.
January 28 - Nanobac Pharmaceuticals Inc. Signs LOI for the Acquisition of DNAPrint Genomics
A Reuters Investment Profile has been released on DNAPrint Genomics, Inc. (OTCBB: DNAG). According to Reuters, “This report is essential reading for any serious investor, providing comprehensive financial information on a company's performance, position and cash flows over the past 3 years, including interim data.” To view the report, visit http://bit.ly/fD2q7T.
UNIVERSAL DETECTION TECHNOLOGY (OTCBB: UNDT)
"Up 16.67% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/UNDT.php
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products.
February 15 - Joint Product Manager-Consequence Management (JPM-CM) CBRN Equipment Database to Include Universal Detection Technology's Bio-Weapons Detection Equipment
JPM-CM Supports the US Army 20th Support Command, National Guard Bureau Weapons of Mass Destruction-Civil Support Teams
Universal Detection Technology (OTCBB: UNDT) (www.udetection.com), a supplier of detection devices that protect against biological, chemical, and radiological threats, announced that its devices have been added to the Joint Product Manager-Consequence Management (JPM-CM) CBRN database. JPM-CM CBD Small Project Acquisition Program's mission is to provide commercial off the shelf (COTS) CBRN equipment capabilities and evaluate new equipment solutions.
The JPM-CM currently supports the US Army 20th Support Command (CBRNE), National Guard Bureau (NGB) Weapons of Mass Destruction-Civil Support Teams (WMD-CST), United States Army Reserve Command (USARC) multi-purpose Chemical Companies assigned a Homeland Defense mission, and other DOD US Government Agencies as required. These units are fielded a wide range of CBRN COTS equipment to support multiple mission scenarios.
The JPM-CM CBRN equipment database is a repository of chemical, biological, radiological, decontamination, sampling, and detection systems designed for protection against various CBRN agents. Information inputted into the database is only accessible to authorized government personnel. The JPM-CM database is designed to be a repository for the manufacturer's information and associated test reports. It is used extensively for decision making and analysis in support of the modernization of COTS equipment for the JPM-CM customers.
"We are honored and pleased to have our CBRN Detection Equipment listed. The fact that the database is used exclusively by government personnel and not by civilians is in line with our strategy of focusing on the government sector," said Jacques Tizabi, UNDT's CEO. "Given the increased role of the National Guard Bureau Weapons of Mass Destruction-Civil Support Teams in CBRN Defense and Mitigation, JPM-CM is a great tool for such teams to evaluate and procure CBRN detection technologies," he added.
LIMELIGHT NETWORKS INCORPORATED (NASDAQ: LLNW)
"Up 28.02% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/LLNW.php
Limelight Networks, Inc. provides solutions that enable business and technology decision makers to profit from the shift of content and advertising to the online world, the explosive growth of mobile and connected devices, and the migration of IT applications and services into the cloud. Over 1800 customers worldwide use Limelight's massively scalable software services to engage audiences, enhance brand presence, analyze viewer preferences, optimize advertising, manage and monetize digital assets, and ultimately build stronger customer relationships.
February 15 - Limelight Networks shares soar on 4Q results
Limelight Networks surges on better-than-expected 4Q results, rosy forecast
Shares of Limelight Networks Inc. (Nasdaq: LLNW) surged Tuesday after the website services provider reported a smaller-than-expected fourth-quarter loss and issued a rosy forecast.
Wedbush Equity Research analyst Kerry Rice noted that the company saw growth in its core content delivery network, which helps websites run faster and gives companies like Netflix Inc. the technology to stream movies, as well as value-added services. That could put Limelight ahead of schedule to meet its goal of generating $400 million in revenue and a 33 percent profit margin before interest, tax, depreciation and amortization by 2014, Rice said.
The company's performance was a surprise given the disappointing forecast recently released by rival Akamai Technologies Inc., said FBR Capital Markets analyst David M. Hilal. More stable pricing, strong traffic growth in its content delivery network as well as its web-based services should drive Limelight's growth in 2011, Hilal said.
"We maintain our Outperform rating as we believe this turnaround story has more legs," Hilal wrote in a note to clients.
Hilal raised his price target to $9 from $8. He also revised his first-quarter forecast, predicting a bigger loss of 5 cents per share on higher revenue of $48.8 million. Previously, he predicted a loss of 2 cents per share on $46.2 million in revenue. Hilal said he broadened his loss estimate because of the company's plan to invest in its business in order to gain more scale.
Limelight expects $48 million to $49.5 million in current-quarter revenue.
Rice of Wedbush stood by his rating of "Outperform" and his $8 price target.
"We believe management has delivered on its promises over the last several quarters, which has improved the performance and perception of Limelight," he wrote in a note to clients.
Rice also revised his fiscal 2011 forecast, predicting more revenue on smaller earnings. He estimates that Limelight will lose 3 cents per share on $215 million in revenue for the full year. Previously, he said it would earn 2 cents per share on $212 million in revenue for the year.
Analysts polled by FactSet predict a current-quarter loss of 2 cents per share on $49 million in revenue. For fiscal 2011, they expect a loss of 5 cents per share on $217 million in revenue.
The stock rose $2.01, or 31 percent, to $8.47 in morning trading.
NEURO-BIOTECH CORPORATION (OTC: MRES)
"Up 35.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MRES.php
Neuro-Biotech Corp. engages in the exploration and development of mineral properties in Canada. The company primarily explores for zinc and copper ores. It holds interests in 292 mining claims located in the Matagami Mining Camp in the province of Quebec. The company was formerly known as M45 Mining Resources Inc. and changed its name to Neuro-Biotech Corp. on June 17, 2010. Neuro-Biotech is based in Montreal, Canada.
February 15 - MRES Board of Directors Accepts Offer
Neuro-Biotech Corp. (OTC: MRES) CEO Dr. Claude Poulin announced to the company’s shareholders that the board of directors have voted to accept the 15-cent offer. Full details will be provided to shareholders at closing of market February 15, 2011.
Poulin announced on February 9 that Neuro-Biotech Corporation (OTC: MRES) received an unsolicited offer for the purchase of all the outstanding shares at $0.15 per share.